The Academy Newsletter, April 2014
Date: 
Wednesday, May 21, 2014

Message from the Outgoing President

 

 Dear Friends and Colleagues,

It is with mixed feelings that I pen my last newsletter article as your president. It has been a pleasure and a privilege to work with our committed volunteer leaders and our talented staff, to tackle problems large and small as we navigate the rapidly changing landscape of continuing education with an eye toward the unique needs of our members.

Our 103rd Annual Meeting, held last month in San Diego, stands as testimony to the continued vitality of our Academy, still the largest gathering of physician pathologists in the world. Indeed this year we again set a new attendance record with a grand total of four thousand seven hundred seventysix registrants, breaking last year’s record by 12 percent! This year we saw a number of new and novel offerings for those lucky enough to make it to San Diego, including Practice Changers, Hot Topics in Pathology, and Off the Clock Talks. All were enthusiastically received by those in attendance, and along the way we learned some lessons about how to make them even better next year! These new additions were balanced over and against the always popular stalwarts of our annual event, including a broad range of offerings at nearly thirty Companion Society meetings; cutting-edge science in our abstract presentations; a glimpse of the future as envisioned by Arul Chinnaiyan in a riveting Timely Topics Lecture; an exemplar of what it means for pathology to drive translational discoveries through team science in the Maude Abbott Lecture delivered by Dr. Ralph Hruban; topics of interest to anyone confronted with diagnostically challenging cases in GI pathology in our 2014 Long Course under the direction of Drs. Joel Greenson and Laura Lamps; real-life clinical dilemmas both common and rare presented by our discipline’s leading subspecialists at our Evening Specialty Conferences; and a breath-taking array of fiftynine short courses that left few bases untouched for anyone trying to keep up with the fast-paced world of diagnostic pathology. Never has it been clearer that our annual meeting remains a worthy home and an industry-leading value for people interested in networking with their peers and expanding their horizons through education.

It has been a year in which your volunteer leaders have been hard at work to ensure a strong future. Our revised bylaws were approved at our 2014 Business Meeting by unanimous consent of members in attendance, and resulted in several important changes to your governance.

  • Your Council is renamed the Board of Directors to be consistent with best practices for nonprofit organizations.
  • The roles of Treasurer and Secretary were established as Board-level positions separate and distinct from the role of Executive Vice President (EVP), to more clearly delineate governance from executive staff leadership. The role of Treasurer was filled by Dr. Julia Dahl, Chair of the Finance Committee; and the role of Secretary, by Dr. John Sinard, a current Board member. Both the Treasurer and the Secretary will be appointed by the Board to three-year terms, renewable by Board approval, without term limits.
  • Board members will continue to be elected for three-year terms but with an opportunity for a second three-year term by Board approval.

These revisions were among several initiatives that bubbled up in the course of a leadership retreat held in October 2013 focusing on governance and executive leadership. The outputs of that retreat reflect a passionate commitment among your volunteer leaders to continuously improve the unique value that accrues to our members. Your Board will continue to invest in defining and implementing strategic priorities for our organization through a refreshed process that will include a strategic planning meeting in June of this year.

While volunteer members focused time and energy on strategic initiatives, our talented and hard-working Augusta staff has had a remarkably productive year! In November they launched an ambitious new website linked to a brand new member database, a project of unprecedented scope that has been sustained, despite operational challenges, only through their singular efforts. In the same month our staff relocated to a new office in Evans, Georgia, that was specifically designed to provide for our space needs over the next five to ten years. And they did all of this while also hosting pathology’s equivalent of the greatest show on earth! That so few can accomplish so much is a phenomenon that has long been part of our brand, a brand that sets us apart from other member organizations and speaks to our continued ability to recruit talented and committed staff to our Academy.

Finally, it has been a privilege to work with Dr. Bruce Smoller as he transitioned out of his role as EVP. Our search committee, under the leadership of Dr. Stuart Schnitt, has been hard at work vetting a highly competitive candidate pool for this prestigious position. Interviews of our finalists will occur in the middle of this month, with a goal of announcing our new EVP sometime this summer or fall.

In the meantime we have worked closely with the ASCP to secure the services of Dr. Blair Holladay as our interim EVP effective April 1st. Dr. Holladay currently serves as Executive Vice President of the ASCP and will continue in this role while also serving as interim executive leader for the USCAP. Blair is recognized, both nationally and internationally, for his dynamic leadership and his expertise in forging collaborative alliances with specialty medical societies. In the course of his tenure at the ASCP, he has focused on globalization initiatives, strategic partnerships in laboratory medicine, corporate reorganization/management activities, humanitarian outreach, health services research, and establishing the gold standard certification for individuals within the United States and abroad. Before coming to ASCP, Dr. Holladay served as the Chief Director for the Center for Cytopathology and Molecular Diagnostics at the Medical University of South Carolina. Please join me in welcoming Dr. Holladay to this interim position while USCAP leaders search for a permanent candidate to head the Academy!

It is with pleasure and confidence that I pass the baton to our new President, Dr. Celeste Powers. Working with our officers, our Board of Directors, our committee chairs, and our staff, she will play a key role in defining a future certain to include innovative solutions built on a tradition of excellence with an unwavering commitment to exceed the expectations of our members. Please join me in welcoming Dr. Powers to her post.

Thank you for the opportunity to serve.

Sincerely,

 

Jeffrey H. Myers, MD
President
USCAP


Message from the Incoming President

 

Dear Friends and Colleagues,

What an honor it is to serve this year as your President. As my term begins, I first want to thank Dr. Jeff Myers, our immediate Past President. Dr. Myers has been steadfast at the helm during key events and transitions this past year and has worked tirelessly with Academy leaders and the national office. Second, I express my thanks to the membership for culminating the year with our largest and most exciting annual meeting to date!

As mentioned above, the passage of the revised bylaws during the 2014 Business Meeting allows us to continue to evolve as a Society to ensure that USCAP remains centered on meeting the changing needs of our membership. This year we have the opportunity to continue to strengthen our Society and engage our current and future members with a renewed sense of purpose. USCAP has, from its inception, delivered outstanding educational activities and products while also providing, through the annual meeting, a large venue for presentation of current research, promoting publication, and connecting with old friends and new colleagues. USCAP is preeminent in the field of pathology education. Now, together with the input and assistance from our membership, we will continue to explore and embrace new educational opportunities that will bring tomorrow’s digital and virtual technology to our constituents today.

An important part of this process is strategic planning. Last year our efforts were directed behind the scenes in governance to establish expectations and procedures for a high functioning Board as well as for an EVP who can rapidly translate strategic objectives into developed programs for USCAP membership. This will ensure the Academy remains central and relevant to our profession. We have also engaged CFAR, a consultant firm with over thirty years’ experience with nonprofit organizations, academic medicine, and health care organizations to partner with a dynamic group of individuals that represent the current breadth and depth of USCAP – as well as those who will be our future. An intensive two-day session will occur in June, and opportunities as well as challenges will be identified as the process unfolds. I am confident that this will be a very successful venture, in large measure because we understand that our members are the heart and soul of USCAP and that their input is essential to this process. So, more to come as this process ramps up!

Also crucial to the future success of the Academy is the selection of the new EVP. As USCAP has evolved, the role of the EVP has changed significantly. Your EVP Search Committee has been charged with selecting an individual who can meet the changing needs of Academy members and execute strategic initiatives with demonstrated skill in all facets of operations management. In addition, and equally important, will be the EVP’s ability to work with the Board to innovate and invigorate with vision and passion for our discipline. I am pleased to report that the search process is well underway. We have outstanding candidates, which has made the selection process both difficult and exciting. A search of this significance takes time, and thus on April 1, 2014, Dr. Blair Holladay assumed the role of interim EVP smoothly and seamlessly. His expertise allows us to continue to press forward with our current initiatives while awaiting the outcome of the search and final approval of the new EVP by the Board.

As Dr. Myers detailed, our 2014 Annual Meeting continues to be highly successful in large part due to the synergism between enthusiastic attendees and our outstanding faculty. I am confident that our next annual meeting, Boston 2015, will continue this tradition of excellence while embracing new educational concepts. For those who know me, you know that I strongly believe in mentoring at the individual level, but also at the organizational level. USCAP will continue to develop meaningful and relevant relationships with our members that foster this concept.

This year we have a new educational course that exemplifies the concept of mentoring and individual education for our members. Under the direction of Dr. Steven Billings, USCAP is excited to present: Interactive Microscopy: Sign Out with the Experts. What better way to experience surgical pathology than one on one with the experts who will not only discuss criteria but also share their personal strategies in diagnosis and communication? Course registrants will review a series of cases at microscopes provided at the event—followed by a multi-head scope interactive tutorial with and discussion about comparison lesions, presented by the experts, to hone diagnostic ability. A variety of subspecialties will be highlighted: breast, gastrointestinal, genitourinary, and gynecologic pathology as well as dermatopathology and frozen section diagnosis in neuropathology. Come meet your mentors in Boston this September 13th and 14th!

For those of you who look forward each year to our other popular educational courses we have a great lineup of faculty and topics in wonderful locations once again. The first, Practical Pathology Seminars, will be held in New York City this May 1–4. The course is designed to provide updated, pragmatic, problem-solving information for practicing anatomic pathologists, and will focus on the resolution of diagnostic pitfalls in an array of difficult areas of surgical pathology. Practical Pathology Seminars offers a total of fifteen hours of CME/SAMs credits this year. Registration is open and online, or you may call the USCAP office (706-733-7550) to register. PPS is followed by Diagnostic Pathology 2014. This year the course will be held from July 20–25 in sunny San Juan, Puerto Rico. The course has been revised, with new faculty, information, and teaching techniques featuring didactic lectures that focus on diagnostically challenging areas for each major organ system or subspecialty area. The faculty integrates teaching on morphology with diagnostic assays, including immunohistochemistry and molecular advances. The course incorporates interactive sessions and is designed to give the participant an opportunity to actively reinforce the learning concepts. Registration will open later this month.

For more information about these terrific courses, visit the USCAP homepage. For those of you who didn’t try our USCAP app—USCAP365—during the Annual Meeting, check it out! This app links you directly to the USCAP website; download it from any app store or by going to www.tripbuilder.com/uscap365.

Our Journals, Laboratory Investigation and Modern Pathology, represent yet another facet of our education portfolio. I am indeed pleased to report that Dr. John Eble, the current editor-in-chief of Modern Pathology, has agreed to continue in that position for another term. Under Dr. Eble’s strong and progressive guidance, Modern Pathology has continued to rank first its immediate peer group, with a recent and impressive increase in Impact Factor of 5.253 compared to the prior year’s 4.794. Dr. Eble’s associate editors and expert Review Board members continue to ensure the publication of strong, contemporary articles relevant to all practicing pathologists.

This year will be pivotal for USCAP as we position ourselves for a strong a vibrant future. The strength of this organization emanates from its members—this is your USCAP. On behalf of the Board and the National Office, I thank you for your support of the Academy and look forward to our partnership as we take USCAP to the next level!


Sincerely,
 
Celeste N. Powers, MD, PhD
President
USCAP

 

 

 

 


New Bylaws Add Two New Positions to the Executive Committee

 

With the membership’s approval of the new bylaws come some significant changes to the governance of our organization. One of these changes is the removal of the Secretary and Treasurer duties from the role of the EVP. Now, these two roles are full and distinct positions and are a part of the USCAP Executive Committee. These positions have a longer tenure than the USCAP president and will assist in the transition of our elected officials.

Please join us in welcoming the newest members of the Executive Committee, Doctors Julia Dahl, Treasurer, and John Sinard, Secretary.

 

Julia Dahl, MD

Dr. Julia Dahl is Chief Executive Officer and Medical Director for Mosaic Pathology Consultants in Memphis Tennessee where she also serves as the Director of Anatomic Pathology Services for Regional One Health. In addition to fully participating in the practice, Dr. Dahl oversees all technical services related to cytopathology, surgical pathology, autopsy pathology, and related ancillary testing. She is also the primary specifications developer for Mosaic’s proprietary electronic health record program - ProSequence. Dr. Dahl completed residency training in anatomic and clinical pathology in Oregon, followed by fellowships in surgical pathology and then gastrointestinal and liver pathology with the late Dr. Rodger Haggitt at the University of Washington. In addition to her interests in inflammatory and allergic conditions of the gastrointestinal tract she has a long standing interest in quality, patient safety and service excellence. She has focused on developing innovative practice models that integrate pathology into the continuum of care in new and novel ways. Dr. Dahl has been a member of USCAP since 1993, presenting poster and platform presentations.

Julia was nominated to serve as Finance Committee member in 2011 and selected to replace Dr. Jim Linder as Finance Committee Chair in 2013. Dr. Dahl brings to the Board and Executive Committee unique experience in financial modeling methods and the perspective of an academically oriented community based private practice pathologist. She also serves as a member of our EVP Search Committee.

 

John Sinard, MD

Dr. John Sinard did his undergraduate training in Biochemical Sciences at Harvard, and then obtained MD and PhD degrees from the Johns Hopkins University School of Medicine. Following that, he did an Anatomic Pathology residency at the Yale New Haven Medical Center, and then joined the faculty at Yale where he has been ever since, working his way up to the rank of Professor. His first book, Outlines in Pathology, has been used by residents for many years to prepare for the Pathology board exam. At Yale, John has held many positions, including director of the Autopsy Service, director of Ophthalmic pathology, and director of the Residency Training Program. He founded and directs the Pathology Informatics program, and authored the first Pathology Informatics book for anatomic pathologists: "Practical Pathology Informatics". He now also serves as the Associate Director of Anatomic Pathology.

In 2006, he became the founding Editor in Chief of the eAcademy, the on-line education arm of the USCAP, for which he designed and help implement the Anatomic Pathology Electronic Case Series (APECS) program. John served on the USCAP Education Committee from 2006 - 2012, and was elected to the USCAP Council (now the Board of Directors) in 2012. He also is a member of the Innovative Educational Products Committee for the USCAP. Outside of the USCAP, John is a member of the Clinical Informatics Steering Committee and the Council on Scientific Affairs for the College of American Pathologists, and the Clinical Laboratory Improvement Advisory Committee for the Centers for Disease Control and Prevention.

 

New Board Members

 

David J. Grignon, M.D.

Dr. David Grignon is Centennial Professor and Vice Chair for Clinical Programs in the Department of Pathology and Laboratory Medicine at Indiana University. He is recognized nationally and internationally for his expertise in the area of Urologic Pathology. He has published over three hundred fifty  research/review articles and twentyseven book chapters. He is an author or editor of five books including the 4th Series AFIP fascicle on Tumors of the Kidney, Bladder, and Related Urinary Structures, a monograph on Gleason Grading of Prostate Cancer and the soon to be released text, Urological Pathology. A major focus of Dr. Grignon’s career has been education and he has presented over three hundred invited lectures and courses in twentyeight countries.

Dr. Grignon has been an active member of the USCAP since 1982. Since presenting his first abstract at the USCAP in 1983, he has participated in over two hundred fifty  abstract presentations at the annual meeting. He has presented five short courses on various subjects in Urologic Pathology and in 2008 Co-Directed the Long Course on Tumors of the Kidney and Urinary Bladder. He has been a faculty member on other USCAP educational programs including Diagnostic Pathology and Practical Seminars in Pathology. Dr. Grignon has served as an abstract reviewer on several occasions (1992-1995, 2000-2004, 2012-present) and has co-chaired many platform sessions as well as presenting at Evening Specialty Conferences. He is a founding member of the International Society of Urological Pathology and is a member of the editorial board of Modern Pathology. Dr. Grignon brings to the Board his energy and commitment to the organization and in particular its educational programs.

 

Julia C. Iezzoni, MD

Dr. Julia C. Iezzoni is an Associate Professor of Pathology at the University of Virginia School of Medicine. Dr. Iezzoni’s clinical expertise is surgical pathology, with subspecialty expertise in hepatopathology. She has published widely on liver disease and has presented multiple national courses and lectures in the field of hepatopathology. In addition, Dr. Iezzoni is the recipient of numerous institutional and university-wide teaching awards for her activities in medical education.

Dr. Iezzoni has been an active member of USCAP for many years and has served on multiple committees within the Academy, as well as participated as evening specialty conference and short course faculty. Also, she is currently chair of the Accreditation Council for Graduate Medical Education (ACGME) Pathology Review Committee. As an USCAP board member, Dr. Iezzoni looks forward to promoting the Academy’s mission of providing practicing pathologists and pathology trainees with readily accessible, high quality, clinically relevant, and up-to-date continuing medical education in anatomic pathology.

 

Audrey J. Lazenby, MD

Dr. Audrey Lazenby is a Professor of Pathology and Director of Anatomic Pathology at the University of Nebraska Medical Center, where she mixes clinical practice, education, administrative duties and research. Six months after arriving in Omaha, she also served for a year as interim chair of the Department of Pathology and Microbiology.

Gastrointestinal Pathology has been the focus of her clinical interest, research and educational efforts, but she maintains a general surgical pathology sign out and even rotates on the autopsy service.

Her first experience with the USCAP was as a 2nd year resident at the Annual Meeting, where she enjoyed the scientific presentations, top notch educational offerings and camaraderie. She has continued to attend, enjoy and be informed at every meeting since. Her service to the USCAP has included being faculty for two short courses, multiple evening specialty conferences, and the IAP and companion meetings. She has also served on the abstract review board, been a platform moderator and been on the Education Committee.

 

 
 

Join Course Director Jesse K. McKenney, MD, and an all-star lineup
of diagnostic specialists to improve your critical diagnostic skills.

Jesse K. McKenney, MD
Course Director
Cleveland Clinic
Jason L. Hornick, MD, PhD
Brigham and Women’s Hospital
Esther Oliva, MD
Massachusetts General Hospital
Kristen A. Atkins, MD
University of Virginia
Christina S. Kong, MD
Stanford University School of Medicine
Brian P. Rubin MD, PhD
Cleveland Clinic
Edi Brogi, MD, PhD
Memorial Sloan Kettering Cancer Center
Teri A. Longacre, MD
Stanford University School of Medicine
Saul Suster, MD
Medical College of Wisconsin
Laura C. Collins, MD
Beth Israel Deaconess Medical Center
Cesar A. Moran, MD
MD Anderson Cancer Center
Carmen Tornos, MD
Stony Brook University Hospital
 
Improve Your Diagnostic StrategiesPractical Pathology SeminarsWhat to do in New YorkRegister Now. Click HereUSCAP homepageUSCAP Seminar Series Info

Interim EVP Overview

 

As you may be aware, USCAP is in the midst of an extensive search for a new Executive Vice President. A search committee under the leadership of Dr. Stuart Schnitt is in the process of vetting a highly competitive candidate pool to identify the next permanent executive leader for your Academy. While this effort continues, we are pleased to announce the appointment of E. Blair Holladay, PhD, SCT (ASCP)CM, as Interim Executive Vice President of USCAP, effective April 1, 2014.

Dr. Holladay currently serves as Executive Vice President of the ASCP and is recognized, both nationally and internationally, for his dynamic leadership and his expertise in forging collaborative alliances with specialty medical societies.

Since joining ASCP in 2005, Dr. Holladay has focused on globalization initiatives, strategic partnerships in laboratory medicine, corporate reorganization/management activities, humanitarian outreach, health services research, and establishing the gold standard certification for individuals within the United States and abroad. Before coming to ASCP, he served as the Chief Director for the Center for Cytopathology and Molecular Diagnostics at the Medical University of South Carolina.

We welcome Dr. Holladay to this interim position while USCAP leaders search for a permanent candidate to head the Academy. During this time, Dr. Holladay will also continue in his role as Executive Vice President of the ASCP.

The USCAP is deeply committed to the future of our discipline. With over ten thousand pathologist members, USCAP has been a leader in the transmission of knowledge in the field of pathology for more than one hundred years. The continued mission of the USCAP is to provide pathologists with high-quality continuing medical education (CME) at the investigative and applied practice level. Your Academy has enjoyed sustained growth, and its leadership is confident and excited about the continued success of our enterprise.

Please welcome Dr. Holladay to his new role as the Interim Executive Vice President of the USCAP.

 


Congratulations To

 

  •   The new members of the Education Committee (under the Direction of Dr. Laura Lamps): Drs Raja Seethala, Amy Chadburn, John Rieth and Dan Milner.
     
  •   The Finance Committee is headed by Dr. Julia Dahl, who will also now serve in the position of Treasurer on the Executive Committee, in keeping with the newly approved revised Bylaws. Dr. John Sinard was selected to serve as the Secretary of the Academy, also an Executive Committee position. The Publications Committee is chaired by Dr. Murray Resnick and Dr. Tarik Tihan will be the new Chair of the Membership Committee. All of the members of the various USCAP Committees are noted on our website
     
  •   John N. Eble, MD, our Editor In Chief for Modern Pathology, will continue leading this outstanding journal.

 
 

Annual Meeting Roundup

 

Photos from the Annual Meeting are posted on our Facebook page

 


Update: Annual Meeting Evaluations and SAMs

 

The evaluations for the 2014 USCAP Annual Meeting are online and available for completion. So too are the majority of SAMs tests; at this point only a few SAMs are missing. We will send an update email to members once all of the SAMs are listed on line.

To access and claim CME/SAMs credits for the USCAP 2014 Annual Meeting, please follow these steps:

  • Go to uscap.org and log in using your USCAP username and password in the login boxes found in the top right corner. If you are unable to locate your log in details, the log in help link is located above the username box.
  • Once logged in, go to your My Profile page. Click on the link for Evaluations/CME/SAMs on the bottom left hand side of the page. This link will take you to the Credit Claim Management page that states 2014 Annual Meeting Evaluation/CME/SAMs.
  • Click there to proceed.


 

 

Eleven Annual Meeting Courses Coming Online

 

We’re pleased to announce that eleven of this year’s annual meeting will soon be available. Keep an eye out for these new online courses in the coming month:

  • SC03 - "Common Dilemmas in Breast Pathology"
  • SC12 - "Surgical Pathology of Blood Vessels"
  • SC20 - "Dermatopathology Greatest Hits"
  • SC28 - "Renal Tumors in Adults"
  • SC32 - "How to Diagnose Clinically Relevant High Risk GYN Precancerous Lesions"
  • SC35 - "Diagnostic Immunohistochemistry: Plagued with Potential Problems but Pregnant with Possibilities"
  • SC41 - "Pattern-Based Algorithms in Diagnostic Liver Pathology"
  • SC46 - "Neuropathology After Dark: Surviving Intraoperative Frozen Section Consult"
  • SC47 - "Glomerular Diseases: Differential Diagnosis, Histologic Variants and New Classifications"
  • SC55 - "Tubulointerstitial and Vascular Diseases of the Kidney"
  • Special Course: "Clinical Application of Next Generation Sequencing for the Management of Patients with solid Tumors"

 
 

SAVE THE DATE

 



The USCAP’s "Diagnostic Pathology Update" will be held in beautiful San Juan, Puerto Rico, in July. Registration will soon be online for this can’t-miss event with leading faculty from North America.
 



Right on the heels of "Diagnostic Pathology Update" is our new course, "Interactive Microscopy: Sign Out with the Experts." Held in Boston this September, attendees of this new USCAP course will be led by authorities from six subspecialties in small focused groups to discuss diagnostic strategies. The response to the course demonstration at the Annual Meeting was fantastic, so be sure sign up early for this one!
 


Pathologists-in-Training Well Represented in San Diego

 

A total of one thousand two hundred fortyseven residents/fellows at our meeting of which one thousand fortyseven were USCAP Junior Members. Each of the last several years we have had greater than one thousand  residents/fellows/students attend our Annual Meetings. The percentage of house staff attending the meeting who are members of the Academy was eightyfour, much higher than in recent years. Our present "steady state" of Junior Members is over two thousand four hundred.

In recent years, the Academy has rolled out a number of initiatives for our Junior Members including:

  • Saturday Leadership Seminar for residents conducted by Dr. Carol Farver (Cleveland Clinic) that was fully subscribed and a huge success. This was the third year of this program and given the initial success, will be augmented at future meetings.
     
  • A second Saturday seminar on Genomics that was offered by
    Dr. Richard Haspel. This program was sold out with a large waiting list and was similarly popular.

     
  • A cocktail reception for residents, members of the USCAP Council and Ambassadors designed for our future leaders to meet our present ones.
     
  • Fellowship Fair with forty–fiftyfive institutions to discuss hundreds of fellowships (this year fortyeight).
     
  • The evening Specialty Conference just for house staff/fellows.
     
  • The House Staff Hospitality Lounge where Academy and Pathology leaders from throughout North America gathered to talk with the house staff. This year we expanded the hours in which refreshments were served.

 

 

Abstracts and Stowell-Orbison Winners

 

Abstracts were submitted from throughout the world (from approximately forty countries and over four hundred fifty academic medical centers and institutions). These scientific abstracts are online; searchable in MyPath by twentyeight subspecialties, disease, technique, author, etc. You may also find the 2014 Annual Meeting abstracts and virtual posters on the annual meeting webpage under the "Past Meetings" heading.

Fiftyfive percent of submitted scientific abstracts had a first author who is a pathologist-in-training, which is similar to that seen in recent years. (This does not count the house staff/fellows that are subsequent authors). Five hundred sixteen Stowell-Orbison abstracts were submitted by junior pathologists and of these three hundred thirteen were accepted (61%). There were three co-equal Stowell-Orbison Awards presented.

The three co-equal recipients, in no specific order, of the Stowell-Orbison Awards are:

  • [104] "Frequent Inactivating Mutations of the Cohesin Complex Gene STAG2 in Ewing's Sarcoma Associated with TP53 Mutations and Poor Outcome"

    David A Solomon, Andrew Brohl, Jung-Sik Kim, Wendy Chang, Young Song, Jose Antonio Lopez Guerrero, Isidro Machado, Zengfeng Wang, Joanna J Phillips, Daniel H Wai, Violette Shahbazian, Poul Sorensen, Andrew E Horvai, Timothy J Triche, Markku Miettinen, Antonio Llombart-Bosch, Todd Waldman, Javed Khan. University of California, San Francisco, CA; Mount Sinai School of Medicine, New York, NY; Georgetown University, Washington, DC; National Cancer Institute, NIH, Gaithersburg, MD; University of Valencia, Valencia, Spain; National Cancer Institute, NIH, Bethesda, MD; Children's Hospital, Los Angeles, CA; University of British Columbia, Vancouver, Canada

     

     
  • [884] "Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Chemotherapy in Muscle Invasive Urothelial Carcinoma"

    Alexander Baras, Nilay Gandi, Enrico Munari, Sheila F Faraj, Mohammad Hoque, Mark Schoenberg, Trinity Bivalacqua, George J Netto. Johns Hopkins University, Baltimore, MD

     

     
  • [895] "MED15, Encoding a Subunit of the Mediator Complex, Is Overexpressed at High Frequency in Castration-Resistant Prostate Cancer"

    Martin Braun, Zaki Shaikhibrahim, Roopika Menon, Anne Offermann, Angela Queisser, Diana Boehm, Wenzel Vogel, Kerstin Ruenauver, Christian Ruiz, Tobias Zellweger, Maria Svensson, Ove Andren, Glen Kristiansen, Nicolas Wernert, Lukas Bubendorf, Sven Perner. University Hospital Bonn, Bonn, Germany; University Bonn, Bonn, Germany; University Basel, Basel, Switzerland; St. Clara Hospital, Basel, Switzerland; University Orebro, Orebro, Sweden; CeGat, Tuebingen, Germany

     

In addition, three abstracts received Stowell-Orbison Honorable Mention:

  • [279] "Extensive Rewiring of Epithelial-Stromal Crosstalk Networks in Breast Cancer"

    Eun-Yeong Oh, Stephen M Christensen, Nicholas W Knoblauch, Laleh Montaser-Kouhsari, Andrew H Beck. Beth Israel Deaconess Medical Center, Boston, MA

     
  • [1547] "Expression, Function and Therapeutic Targeting of the CD70-CD27 Signaling Pathway in Acute Myeloid Leukemia"

    Christian M Schurch, Carsten Riether, Adrian F Ochsenbein. Institute of Pathology, Bern, Switzerland; University of Bern, Bern, Switzerland; University Hospital Bern, Bern, Switzerland

     
  • [1558] "Detection of T-Cell Clonality by Next-Generation Sequencing in Mycosis Fungoides"

    Kari E Sufficool, Christina M Lockwood, Ian S Hagemann, Jonathan A Schumacher, Todd W Kelley, Eric J Duncavage. Washington University School of Medicine, St. Louis, MO; ARUP Laboratories, Salt Lake City, UT; University of Utah School of Medicine, Salt Lake City, UT

More photos posted on our Facebook page

 

Other Award Winners

 

The Benjamin Castleman Award (for the most outstanding paper in the field of human pathology) was awarded to Dr. Valetina Nardi from Massachusetts General Hospital for the paper, “Detection of Novel Actionable Genetic Changes in Salivary Duct Carcinoma Helps Direct Patient Treatment” that was published in Clinical Cancer Research, 2013; 15: 480-490. The Award was presented by Dr. David Louis from Massachusetts General Hospital in Boston.

The F. Stephen Vogel Award (for the most outstanding paper published in an Academy journal by a pathologist-in-training) went to Dr. Ghassan Allo for the paper, “ARID1A loss correlated with mismatch repair deficiency and intact p53 in high-grade endometrial carcinomas”, published in Modern Pathology.

 

 

Eightysix Runners Participate in the USCAP Foundation’s Miles for Mentors Race

 

Eightysix very enthusiastic contestants speedily, others a bit more casually, left the front of the Hilton hotel March 3 for a 5K in honor of their mentors. The race course – a beautiful loop around the San Diego waterfront – was completed by first place winners Kate Schwetye (who ran in honor of Dr. Phyllis Huettner) and David Farnell (Honoring his mentor Dr. Anita Bane), both USCAP Junior Members. All of the runners were met with high fives, a runner’s breakfast, and smiles all around. See you next year in Boston!
 

   
   
   

More photos posted on our Facebook page

 

Outside of the USCAP

 

Companion Diagnostics: From Biomarker Identification to Market Entry

Date: April 28-29, 2014
Location: The New York Academy of Sciences
7 World Trade Center, 250 Greenwich St, 40th Fl
New York, NY 10007

Register by April 4, 2014 and Save!

Keynote Panelists:
Elaine Collier, MD, National Center for Advancing Translational Sciences/NIH
Mikael Dolsten, MD, PhD, Pfizer Inc
Michael Kolodziej, MD, FACP, Aetna
Reena Phillip, PhD, U.S. Food & Drug Administration
Charles L. Sawyer, MD, Memorial Sloan-Kettering Cancer Center

Conference Description:
This two–day conference will provide a neutral forum for international scientists and clinicians from academia, industry, and government—as well as healthcare policy makers, regulatory experts, insurance sector representatives, and other stakeholders—to discuss research, financial, and regulatory strategies that will facilitate CDx development and integration into clinical care.

Presentations will illustrate successes and failures based on case studies; evaluate emerging applications of technologies such as epigenetics, bioinformatics, and nanotechnology; analyze diverse therapeutic target areas including cancer as well as inflammatory, infectious, cardiovascular, metabolic, and neurodegenerative diseases; recognize regulatory hurdles; and formulate solutions to better improve public health with CDx and personalized medicine.